top of page

Transforming healthcare for people living with chronic conditions.

The world's most accurate implantable sensor for hydrocephalus.

NEWS

Dr Sarah-Jane Guild

Pressure-guided management of chronic disease.

The Kitea System enables early intervention and delivers better outcomes at every level, through the next generation of micro-implantable devices.

Hydrocephalus: from reactive to proactive care.

Caused by a buildup of excess fluid in the brain, hydrocephalus is a serious, lifelong condition.

The condition disproportionately affects children, and it is generally fatal without treatment. The main treatment path places a shunt in the brain to drain excess fluid and prevent a rise in pressure.

The Current Timeline of Management

Shunt failure is common

Highest failure rate of any implanted medical device

Symptoms are confusing

Shunt failure can mimic common illnesses

Requires hospital admission

Assessment of failure is complex and expensive

Significant risks

Increase in intracranial pressure can be life threatening

NormalTimeline.png

A better way with Kitea

The Kitea System aims to eliminates guesswork by enabling pressure measurement at home and in hospital for the first time.

Proposed Timeline of Managment 

Enable.png
Measure.png
Manage.png
Resolve.png
WandDiagramClear.png

Improving outcomes at every level.

Surgeons In surgery

For patients

  • Reduced inequity in healthcare access

  • Monitor symptoms any time, any place

  • Early detection, less time in hospital

For hospitals
  • Estimated 30% reduction in costs

  • Fewer CT, MRI and other imaging procedures

  • Better clinical outcomes

For payers
  • Significant reduction in insurance costs

  • Better outcomes for patients

  • Reimbursement codes available for remote monitoring

Our partners

Our accolades

unnamed (3).jpg
CI-2023-0039 Ārohia Recipient Banner 2023_LARGE.png
bbs-affiliate-medical-alley-website_0.png
images (1).png
Short-Te-Wiki-NBR-Mast-head-2.webp
images.png
download.png
9cbadedd4ff3a51823a1fe60e51b5f18.jpg
download.jpeg
images.png
download.jpeg
HTA_2025_WinnersLogo_Horizontal.png
5587252_EOY Finalist logos.jpg
2DABA-Logo-Main.png

Contact the team.

Thanks, we received your message!

Sources: Hydrocephalus
 

1. Hydrocephalus Association; About Hydrocephalus

2. Simon TD, Riva-Cambrin J, Srivastava R, Bratton SL, Dean JM, Kestle JR; Hydrocephalus Clinical Research Network. Hospital care for children with hydrocephalus in the United States: utilization, charges, comorbidities, and deaths. J Neurosurg Pediatr. 2008 Feb;1(2):131-7.

3. Reddy GK, Bollam P, Caldito G. Long-Term Outcomes of Ventriculoperitoneal Shunt Surgery in Patients with Hydrocephalus. World Neurosurgery. 2014;81(2):404-10.

4. Chern JJ, Macias CG, Jea A, Curry DJ, Luerssen TG, Whitehead WE. Effectiveness of a clinical pathway for patients with cerebrospinal fluid shunt malfunction. Journal of Neurosurgery: Pediatrics. 2010;6(4):318-24

5. Naftel RP, Tubergen E, Shannon CN, Gran KA, Vance EH, Oakes WJ, et al. Parental recognition of shunt failure: a prospective single-institution study. Journal of Neurosurgery: Pediatrics. 2012;9(4):363-71.

6. Barber, J.M., et al., Telemetric intra-cranial pressure monitoring: clinical and financial considerations. British Journal of Neurosurgery, 2017. 31(3): p. 300-306.

© 2023 Kitea Health Ltd


New Zealand
Level 3, 24 Balfour Road

Parnell, Auckland 1052, New Zealand 

+64 9 300 3299

United States of America

2140 South Dupont Hwy

Camden, 19934 Delaware, USA
+1 302 336 8883

 

The Kitea System is not currently approved for clinical use.

bottom of page